BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16310227)

  • 1. Among the twenty classical L-amino acids, only glutamate directly activates metabotropic glutamate receptors.
    Frauli M; Neuville P; Vol C; Pin JP; Prézeau L
    Neuropharmacology; 2006 Feb; 50(2):245-53. PubMed ID: 16310227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glutamate transporter and receptor ligands on neuronal glutamate uptake.
    Boeck CR; Kroth EH; Bronzatto MJ; Jardim FM; Souza DO; Vendite D
    Neurosci Res; 2005 Sep; 53(1):77-83. PubMed ID: 16011854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G protein-coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain.
    Parmentier ML; Joly C; Restituito S; Bockaert J; Grau Y; Pin JP
    Mol Pharmacol; 1998 Apr; 53(4):778-86. PubMed ID: 9547371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel metabotropic glutamate receptor negatively coupled to adenylyl cyclase in cultured rat cerebellar astrocytes.
    Kanumilli S; Toms NJ; Roberts PJ
    Glia; 2004 Apr; 46(1):1-7. PubMed ID: 14999808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells.
    Kalariti N; Lembessis P; Koutsilieris M
    Anticancer Res; 2004; 24(6):3923-9. PubMed ID: 15736433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Group II and Group III metabotropic glutamate receptors by endogenous ligand(s) and the modulation of synaptic transmission in the superficial superior colliculus.
    Thompson H; Neale SA; Salt TE
    Neuropharmacology; 2004 Nov; 47(6):822-32. PubMed ID: 15527816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
    Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
    Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
    Cahusac PM; Wan H
    Neuroscience; 2007 Apr; 146(1):202-12. PubMed ID: 17346894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function.
    Canela L; Fernández-Dueñas V; Albergaria C; Watanabe M; Lluís C; Mallol J; Canela EI; Franco R; Luján R; Ciruela F
    J Neurochem; 2009 Oct; 111(2):555-67. PubMed ID: 19694902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors.
    Hermit MB; Greenwood JR; Nielsen B; Bunch L; Jørgensen CG; Vestergaard HT; Stensbøl TB; Sanchez C; Krogsgaard-Larsen P; Madsen U; Bräuner-Osborne H
    Eur J Pharmacol; 2004 Feb; 486(3):241-50. PubMed ID: 14985045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
    Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
    Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
    Arcella A; Carpinelli G; Battaglia G; D'Onofrio M; Santoro F; Ngomba RT; Bruno V; Casolini P; Giangaspero F; Nicoletti F
    Neuro Oncol; 2005 Jul; 7(3):236-45. PubMed ID: 16053698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
    Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
    Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-carboxy-4-phosphonocyclopentane amino acids: new metabotropic glutamate receptor ligands.
    Bessis AS; Vadesne G; Bourrat E; Bertho G; Pin JP; Acher FC
    Amino Acids; 2003 Apr; 24(3):303-10. PubMed ID: 12707813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity.
    Kniazeff J; Bessis AS; Maurel D; Ansanay H; Prézeau L; Pin JP
    Nat Struct Mol Biol; 2004 Aug; 11(8):706-13. PubMed ID: 15235591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.
    Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Taracha E; Skórzewska A; Lehner M; Bidziński A; Hamed A; Wisłowska-Stanek A; Płaźnik A
    Brain Res; 2009 Jul; 1282():20-7. PubMed ID: 19481536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1.
    Fumagalli E; Funicello M; Rauen T; Gobbi M; Mennini T
    Eur J Pharmacol; 2008 Jan; 578(2-3):171-6. PubMed ID: 18036519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation.
    Oliveira JF; Krügel U; Köles L; Illes P; Wirkner K
    Neuropharmacology; 2008 Sep; 55(4):447-53. PubMed ID: 18680754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic gestational treatment with the adenosine A1 receptor agonist R-phenylisopropyladenosine on metabotropic glutamate receptors/phospholipase C pathway in maternal and fetal brain.
    León DA; Albasanz JL; Castillo CA; Iglesias I; Martín M
    J Neurosci Res; 2008 Nov; 86(15):3295-305. PubMed ID: 18615645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.